Market Overview

Morgan Stanley Hopes for Some Retail Therapy for Humana

Related HUM
Benzinga's Top Initiations
Aetna Could Outperform Market After Selloff, With Or Without Humana
Molina Healthcare Rises on Asset Acquisition Announcement (Zacks)

In a report published Thursday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on Humana (NYSE: HUM).

In the report, Morgan Stanley noted, “HUM maintained its 2014 EPS outlook of $7.25 to $7.75, but increased its Medicare Advantage, Part D, and commercial individual enrollment outlook on the heels of 4Q. We have lowered our FY14 EPS by $0.05 to $7.70, which reflects higher revenue from new lives, but a lower overall pre-tax margin.”

Humana closed on Wednesday at $95.71.

Latest Ratings for HUM

Sep 2015JP MorganInitiates Coverage onOverweight
Sep 2015RBC CapitalMaintainsSector Perform
Jul 2015SusquehannaMaintainsNeutral

View More Analyst Ratings for HUM
View the Latest Analyst Ratings

Posted-In: Andrew Schenker Morgan StanleyAnalyst Color Reiteration Analyst Ratings


Related Articles (HUM)

Get Benzinga's Newsletters